4//SEC Filing
O'Connor Daniel J. 4
Accession 0000950170-23-069446
CIK 0001990550other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:15 PM ET
Size
5.5 KB
Accession
0000950170-23-069446
Insider Transaction Report
Form 4
O'Connor Daniel
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-12-11+750,000→ 1,363,332 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") payable in common stock of the Issuer granted to the Reporting Person on December 11, 2023 (the "Grant Date"). The RSUs were granted in connection with the completion of the year-end review process and will be issued pursuant to the Company's Amended and Restated 2021 Equity Incentive Plan. The award represents an aggregate of the Reporting Person's year-end and make-whole awards based on market data for similarly situated officers at peer companies.
- [F2]The RSUs will vest over thirty-six (36) months as follows: (i) one-sixth (1/6) of the RSUs will vest on the six (6)-month anniversary of the Grant Date, and (ii) one-twelfth (1/12) of the RSUs will vest on a quarterly basis thereafter.
Documents
Issuer
Ambrx Biopharma, Inc.
CIK 0001990550
Entity typeother
Related Parties
1- filerCIK 0001376847
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:15 PM ET
- Size
- 5.5 KB